LEHI, Utah — A Utah-based pharmaceutical company on Thursday announced its plans to provide insulin for diabetics at a"significantly" lower cost.
Over the past decade, the cost of life-saving insulin has skyrocketed. Forcing diabetics to ration their medication or go without. This can lead to all sorts of dangerous medical issues including comas and death. — Civica Rx March 3, 2022 Civica said the availability of affordable insulin will benefit people with diabetes who have been forced to choose between life sustaining medicines and living expenses, particularly those uninsured or underinsured who often pay the most out of pocket for their medications.HUGE news from Utah-based Civica. Families should never have to choose between life-saving medicine and things like food or housing.
“Diabetes is arguably America’s most expensive chronic condition, and it is heartbreaking that millions of people are rationing their care and putting their lives at risk because they can no longer afford insulin,” said Dan Liljenquist, Board Chair of Civica and the innovator behind Civica’s non-profit business model. “Through mission-driven partnerships, we are choosing to create a new market reality where no one is forced to ration essential diabetes medications.